Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$859M |
| 2 |
Progressive
PGR
|
+$429M |
| 3 |
Netflix
NFLX
|
+$368M |
| 4 |
Danaher
DHR
|
+$364M |
| 5 |
Adobe
ADBE
|
+$343M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
+$710M |
| 2 |
Microsoft
MSFT
|
+$619M |
| 3 |
NVIDIA
NVDA
|
+$447M |
| 4 |
Eli Lilly
LLY
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$373M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.04% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Booz Allen Hamilton
BAH
$12.5B
| $41.1M | 0.03% |
368,665
-69,028
| -16% | -$7.7M |
|
427
Piper Sandler
PIPR
$5.92B
| $41.1M | 0.03% |
317,797
+69,845
| +28% | +$9.03M |
|
428
Janus Henderson AAA CLO ETF
JAAA
$25B
| $40.9M | 0.03% |
820,689
-123,807
| -13% | -$6.17M |
|
|
DOC
429
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $40.5M | 0.03% |
2,894,273
+346,354
| +14% | +$4.85M |
|
430
Martin Marietta Materials
MLM
$37.1B
| $40.5M | 0.03% |
87,661
-5,326
| -6% | -$2.46M |
|
431
Hancock Whitney
HWC
$5.36B
| $40.3M | 0.03% |
1,049,307
+217,539
| +26% | +$8.35M |
|
432
Illinois Tool Works
ITW
$77B
| $40.2M | 0.03% |
160,805
-162,064
| -50% | -$40.5M |
|
433
Jazz Pharmaceuticals
JAZZ
$7.73B
| $39.9M | 0.02% |
322,200
-360,773
| -53% | -$44.7M |
|
434
Shift4
FOUR
$5.89B
| $39.6M | 0.02% |
582,889
+15,311
| +3% | +$1.04M |
|
|
CLVT.PRA
435
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $39.2M | 0.02% |
955,143
-99,234
| -9% | -$4.07M |
|
436
IDEAYA Biosciences
IDYA
$2.2B
| $39.2M | 0.02% |
1,667,523
+1,009,626
| +153% | +$23.7M |
|
437
Ambarella
AMBA
$3.56B
| $39.1M | 0.02% |
467,256
+3,358
| +0.7% | +$281K |
|
438
Impinj
PI
$5.64B
| $38.9M | 0.02% |
434,166
+179,526
| +71% | +$16.1M |
|
439
Artisan Partners
APAM
$3.25B
| $38.8M | 0.02% |
986,805
+154,989
| +19% | +$6.09M |
|
440
OmniAb
OABI
$225M
| $38.7M | 0.02% |
7,692,211
+1,073,985
| +16% | +$5.4M |
|
|
ITCI
441
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $38.7M | 0.02% |
610,915
-163,625
| -21% | -$10.4M |
|
442
NCR Voyix
VYX
$1.74B
| $38.6M | 0.02% |
2,494,578
-672,419
| -21% | -$10.4M |
|
|
AZPN
443
DELISTED
Aspen Technology Inc
AZPN
| $38.1M | 0.02% |
227,032
-438
| -0.2% | -$73.4K |
|
444
Itron
ITRI
$5.37B
| $38M | 0.02% |
527,620
-139
| -0% | -$10K |
|
445
Hanover Insurance
THG
$6.35B
| $37.6M | 0.02% |
332,722
-22,059
| -6% | -$2.49M |
|
446
Graphic Packaging
GPK
$6.07B
| $37.5M | 0.02% |
1,562,142
-21,479
| -1% | -$516K |
|
447
Canadian Pacific Kansas City
CP
$68.2B
| $37.5M | 0.02% |
463,864
-60,249
| -11% | -$4.87M |
|
448
Sweetgreen
SG
$1.02B
| $37.5M | 0.02% |
2,922,362
-398,432
| -12% | -$5.11M |
|
449
Axalta
AXTA
$6.69B
| $37.5M | 0.02% |
1,141,465
+3,717
| +0.3% | +$122K |
|
450
Steven Madden
SHOO
$2.21B
| $37.3M | 0.02% |
1,139,755
+93,128
| +9% | +$3.04M |
|